These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7888700)

  • 21. Phase I pharmacologic study of a new Vinca alkaloid: navelbine.
    Mathé G; Reizenstein P
    Cancer Lett; 1985 Jul; 27(3):285-93. PubMed ID: 4016723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of 7-N-(2-((2-(gamma-L-glutamylamino) ethyl) dithio) ethyl) mitomycin C (KW2149) against human tumor xenografts serially transplanted into nude mice.
    Kubota T; Inada T; Inoue S; Kuzuoka M; Arisawa Y; Suto A; Kodaira S; Ishibiki K; Abe O
    Jpn J Clin Oncol; 1989 Sep; 19(3):216-21. PubMed ID: 2554025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer.
    Depierre A; Lemarie E; Dabouis G; Garnier G; Jacoulet P; Dalphin JC
    Am J Clin Oncol; 1991 Apr; 14(2):115-9. PubMed ID: 1851385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral administration of [3H]navelbine in patients: comparative pharmacokinetics using radioactive and radioimmunologic determination methods.
    Rahmani R; Zhou XJ; Boré P; Van Cantfort J; Focan C; Cano JP
    Anticancer Drugs; 1991 Aug; 2(4):405-10. PubMed ID: 1797198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biliary elimination and pharmacokinetics of vinorelbine in micropigs.
    Levêque D; Merle-Melet M; Bresler L; Didelot JP; Aymard JP; Wihlm J; Jehl F
    Cancer Chemother Pharmacol; 1993; 32(6):487-90. PubMed ID: 8258199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective combination therapy of metastatic murine solid tumors with edatrexate and the vinca alkaloids, vinblastine, navelbine and vindesine.
    Otter GM; Sirotnak FM
    Cancer Chemother Pharmacol; 1994; 33(4):286-90. PubMed ID: 8281620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
    Kanazawa J; Morimoto M; Ohmori K
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats.
    Rahmani R; Guéritte F; Martin M; Just S; Cano JP; Barbet J
    Cancer Chemother Pharmacol; 1986; 16(3):223-8. PubMed ID: 3698163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vinorelbine on the growth of human myeloma cell lines in vitro.
    Ochiai N; Shimazaki C; Inaba T; Fuchida S; Okano A; Hatsuse M; Hirai H; Ashihara E; Fujita N; Nakagawa M
    Leuk Res; 2002 Aug; 26(8):731-8. PubMed ID: 12191568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
    Goa KL; Faulds D
    Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
    Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
    Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human hepatic uptake of two vinca alkaloids: navelbine and vincristine.
    Rahmani-Jourdheuil D; Coloma F; Placidi M; Rahmani R
    J Pharm Sci; 1994 Apr; 83(4):468-71. PubMed ID: 8046598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
    Rowinsky EK; Noe DA; Trump DL; Winer EP; Lucas VS; Wargin WA; Hohneker JA; Lubejko B; Sartorius SE; Ettinger DS
    J Clin Oncol; 1994 Sep; 12(9):1754-63. PubMed ID: 8083697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo.
    McKeage MJ; Kelland LR; Boxall FE; Valenti MR; Jones M; Goddard PM; Gwynne J; Harrap KR
    Cancer Res; 1994 Aug; 54(15):4118-22. PubMed ID: 8033145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
    Toussaint C; Izzo J; Spielmann M; Merle S; May-Levin F; Armand JP; Lacombe D; Tursz T; Sunderland M; Chabot GG
    J Clin Oncol; 1994 Oct; 12(10):2102-12. PubMed ID: 7931480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
    Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
    J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical pharmacokinetics of vinca alkaloids].
    Rahmani R; Samak R; Bore P; Cano JP
    Bull Cancer; 1988; 75(2):195-200. PubMed ID: 3359064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells.
    Li H; Sun L; Li H; Lv X; Semukunzi H; Li R; Yu J; Yuan S; Lin S
    Cell Death Dis; 2017 May; 8(5):e2810. PubMed ID: 28542137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.